Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sinopharm Dongfeng General Hospital is a large-scale, comprehensive Grade 3A tertiary hospital located in Shiyan, Hubei Province, China. Originally established to serve the Dongfeng Motor Corporation, it is now a core member of the Sinopharm Dongfeng Healthcare Group under the China National Pharmaceutical Group (Sinopharm). The hospital serves as a primary teaching affiliate for the Hubei University of Medicine and is a recognized center for medical treatment, scientific research, and professional medical education. It features specialized departments in cardiology, oncology, and orthopedics, and is equipped with advanced diagnostic and therapeutic technologies. Additionally, the institution is a certified National Drug Clinical Trial Institution, supporting clinical research and development within the Chinese healthcare ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sinopharm Dongfeng General Hospital.